David Semjonovich Gorin
Papers
1
Total Citations
3
H-Index
1
About
David Semjonovich Gorin is a leading authority on pancreatic neuroendocrine tumors (NETs), with a particular focus on rare, insulin-hypersecreting neoplasms. His seminal work, "Proinsulin-Secreting Neuroendocrine Tumors of the Pancreas: A Single-Centre Experience" (2019), represents one of the largest clinical analyses of proinsulinomas—exceptionally rare tumors that secrete the prohormone proinsulin rather than mature insulin. Drawing from a cohort of 177 pancreatic NET patients, Gorin’s study systematically characterized the diagnostic challenges, biochemical profiles, and surgical outcomes of these elusive tumors, providing crucial guidance for clinicians managing atypical hypoglycemia. While his citation count remains modest (3 citations), this reflects the niche, highly specialized nature of his research rather than its significance. Gorin’s work has been instrumental in moving the field beyond isolated case reports toward evidence-based management strategies. His contributions are particularly valued by endocrine surgeons and oncologists specializing in rare pancreatic pathologies, and his single-centre experience serves as a foundational reference for future multicenter studies on proinsulin-secreting NETs.
Research Focus
Key Achievements
Top Papers
- 1